Bioqual Basic EPS 2010-2024 | BIOQ
Bioqual basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Bioqual Annual Basic EPS |
| 2024 |
$0.54 |
| 2023 |
$0.93 |
| 2022 |
$5.88 |
| 2021 |
$7.08 |
| 2020 |
$4.74 |
| 2019 |
$3.17 |
| 2018 |
$4.10 |
| 2017 |
$4.44 |
| 2016 |
$3.22 |
| 2015 |
$2.13 |
| 2013 |
$-0.10 |
| 2012 |
$0.24 |
| 2011 |
$0.45 |
| 2010 |
$0.46 |
| 2009 |
$1.46 |
| Bioqual Quarterly Basic EPS |
| 2024-08-31 |
$-0.76 |
| 2024-05-31 |
$-1.32 |
| 2024-02-29 |
$0.31 |
| 2023-11-30 |
$0.54 |
| 2023-08-31 |
$1.01 |
| 2023-05-31 |
$-0.80 |
| 2023-02-28 |
$-1.27 |
| 2022-11-30 |
$1.45 |
| 2022-08-31 |
$1.55 |
| 2022-05-31 |
$2.11 |
| 2022-02-28 |
$0.96 |
| 2021-11-30 |
$1.27 |
| 2021-08-31 |
$1.54 |
| 2021-05-31 |
$2.38 |
| 2021-02-28 |
$1.09 |
| 2020-11-30 |
$1.63 |
| 2020-08-31 |
$1.98 |
| 2020-05-31 |
$1.45 |
| 2020-02-29 |
$0.81 |
| 2019-11-30 |
$1.00 |
| 2019-08-31 |
$1.48 |
| 2019-05-31 |
$1.30 |
| 2019-02-28 |
$0.52 |
| 2018-11-30 |
$0.64 |
| 2018-08-31 |
$0.70 |
| 2018-05-31 |
$1.51 |
| 2018-02-28 |
$0.89 |
| 2017-11-30 |
$0.81 |
| 2017-08-31 |
$0.88 |
| 2017-05-31 |
$1.24 |
| 2017-02-28 |
$0.94 |
| 2016-11-30 |
$1.14 |
| 2016-08-31 |
$1.12 |
| 2016-05-31 |
$1.58 |
| 2016-02-29 |
$0.61 |
| 2015-11-30 |
$0.77 |
| 2015-08-31 |
$0.26 |
| 2015-05-31 |
$0.68 |
| 2015-02-28 |
$0.34 |
| 2014-08-31 |
$0.49 |
| 2014-05-31 |
$0.34 |
| 2013-11-30 |
$0.23 |
| 2013-08-31 |
$0.19 |
| 2013-05-31 |
$0.04 |
| 2012-05-31 |
$-0.43 |
| 2012-02-29 |
$0.21 |
| 2011-11-30 |
$0.15 |
| 2011-08-31 |
$0.30 |
| 2011-05-31 |
$0.25 |
| 2011-02-28 |
$0.09 |
| 2010-11-30 |
$0.12 |
| 2010-08-31 |
$-0.01 |
| 2010-05-31 |
$0.32 |
| 2010-02-28 |
$0.14 |
| 2009-11-30 |
$0.04 |
| 2009-08-31 |
$0.16 |
| 2009-05-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.059B |
$0.059B |
|
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|
